6505--INTENT TO SOLE SOURCE- GALIFOLD 123MG
ID: 36C24725Q0299Type: Special Notice
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF247-NETWORK CONTRACT OFFICE 7 (36C247)AUGUSTA, GA, 30904, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/470ab3b76a014eb291c9c190ee46ffaa/view
Timeline
    Description

    The Department of Veterans Affairs intends to procure Galafold (migalastat) 123mg through a sole source solicitation, specifically identified as 36C24725Q0299. This procurement is crucial for the Veterans Affairs healthcare system, as Galafold is a specialized pharmaceutical product necessary for treating specific medical conditions affecting veterans. The contracting office, located in Augusta, Georgia, has set a response deadline for January 21, 2025, at 12:00 PM Eastern Time, and interested parties should direct their inquiries to Holly Bowing via email, as Recovery Act funds are not applicable for this procurement. The notice will be archived 60 days after the response deadline.

    Point(s) of Contact
    Holly BowingContract Specialist
    EMAIL ONLY
    Holly.Bowling@va.gov
    Files
    Title
    Posted
    36C24725Q0299.docx
    The document serves as a Special Notice regarding the Department of Veterans Affairs' intent to procure Galifold 123MG through a sole source solicitation (36C24725Q0299). The contracting office is located in Augusta, Georgia, with a response deadline set for January 21, 2025, at 12:00 PM Eastern Time. The product falls under the Product Service Code 6505 and NAICS Code 325412, indicating that it pertains to pharmaceutical products. Holly Bowing, the contract specialist, is the primary contact for inquiries, emphasizing that communication should occur via email. The notice states that Recovery Act funds are not applicable and will be archived 60 days after the response deadline. This notice illustrates a targeted procurement strategy for a specific medical product essential for the Veterans Affairs healthcare system, ensuring timely delivery to meet veterans' needs.
    Lifecycle
    Title
    Type
    6505--INTENT TO SOLE SOURCE- GALIFOLD 123MG
    Currently viewing
    Special Notice
    Similar Opportunities
    6505--762-25-1-040-0496 -Tucson CMOP MESALAMINE -(VA-25-00029547)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, through its Network Contracting Office 15, is seeking proposals for the procurement of MESALAMINE 375MG SA capsules, specifically requiring 1,200 bottles (120 capsules each) for delivery to the Tucson CMOP facility. This solicitation, numbered 36C77025Q0098, is set aside for small businesses and aims to ensure the timely availability of essential pharmaceuticals for veterans' healthcare needs. Interested vendors must submit their offers, including a signed SF1449 form, a price schedule, proof of state wholesale distributor licensure, and a Buy American Act certificate, by January 21, 2025. Proposals should be directed to Contract Specialist Jennifer Coleman at Jennifer.Coleman4@va.gov, with compliance to the Drug Supply Chain Security Act being a critical requirement for consideration.
    6505--Metformin SA Tablets REPACK PROGRAM
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Metformin SA Tablets through its Repack Program, aimed at ensuring a stable supply of essential pharmaceuticals for veteran healthcare. Bidders are required to adhere to strict FDA good manufacturing practices, propose pricing that includes a 0.5% Cost Recovery Fee, and comply with the Drug Supply Chain Security Act regulations, among other requirements. This procurement is critical for maintaining the availability and quality of medications for veterans, reflecting the government's commitment to their healthcare needs. Interested contractors must submit their offers by January 21, 2025, at 2:30 PM CST, and can direct inquiries to Senior Contract Specialist Teresa Hussain at teresa.hussain@va.gov.
    6505--ILLUCCIX PSMA VASD
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA), through the Network Contracting Office (NCO) 22, intends to award a sole source firm-fixed price contract to Cardinal Health 414, LLC for the procurement of Illuccix PSMA radioactive therapy injections. This procurement is justified under FAR 8.405-6(a)(1)(B), as only one source can provide the unique supplies necessary for treating prostate cancer patients undergoing Positron Emission Tomography (PET) imaging. The Illuccix PSMA injection is FDA approved for patients with prostate cancer, particularly for those whose cancer may have metastasized or recurred, making it a critical component in their treatment. Interested parties must submit a tailored capability statement and relevant company information by 10:00 AM PT on January 21, 2025, to Hestia.Sim@va.gov, as the VA reserves the right to proceed with Cardinal Health if no adequate responses are received.
    6505--Baclofen Tablets (VA-25-00026620)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking proposals for the supply of Baclofen tablets through its Pharmaceutical Prime Vendor Program, with the solicitation titled "6505--Baclofen Tablets (VA-25-00026620)." The primary objective of this procurement is to establish a reliable source for various strengths of Baclofen tablets, ensuring consistent availability and quality at pre-negotiated prices, while also requiring compliance with the Drug Supply Chain Security Act and Good Manufacturing Practices as evaluated by the FDA. This contract is crucial for maintaining the supply of necessary pharmaceuticals across VA facilities, addressing issues related to compliance, backorders, and recalls. Interested offerors must submit their bids, including pricing for the base year and four one-year options, along with a 0.5% Cost Recovery Fee, and can direct inquiries to Contracting Officer Adrienne A Albachiara at Adrienne.Albachiara@va.gov.
    6505--761-25-1-015-0002 -Chelmsford CMOP 7 PHARMACEUTICALS (VA-25-00012193)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to supply thirteen specific pharmaceuticals for delivery to the Chelmsford Consolidated Mail Outpatient Pharmacy (CMOP) in Massachusetts. The procurement includes items such as Clomiphene Citrate and various Amlodipine/Benzapril combinations, with strict requirements for compliance with the Drug Supply Chain Security Act and a minimum one-year shelf life upon delivery. This initiative is crucial for maintaining an adequate pharmaceutical inventory to support the healthcare needs of veterans. Interested vendors must submit their proposals by December 2, 2024, including a signed SF1449 form, a completed pricing schedule, proof of a valid State Wholesale Distributor License, and a Trade Agreements Act certificate, directed to Contracting Officer Kelley Cunningham at kelley.cunningham@va.gov.
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0117 770-25-2-0182 - National CMOP T0224 TERBINAFINE HCL 1% CREAM
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to fulfill an emergency procurement of Terbinafine HCL 1% Cream for its Consolidated Mail Outpatient Pharmacy (CMOP) facilities across multiple locations. This acquisition, identified by solicitation number 36C77025Q0117, is set aside for small businesses and requires vendors to provide specific documentation, including a completed price schedule in Excel format and a state wholesale distributor license, to ensure compliance with the Drug Supply Chain Security Act. The timely delivery of these pharmaceuticals is crucial for maintaining a reliable supply for veterans, with a delivery timeframe of 10 days after receipt of order and shipments directed to seven designated CMOP locations. Interested vendors must submit their quotes by January 23, 2025, with an estimated award date of January 28, 2025; for further inquiries, contact Michael W. McAlhaney at Michael.McAlhaney@va.gov or (913) 684-0134.
    6505--Tamsulosin Capsules
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0011 concerning the procurement of Tamsulosin Hydrochloride (HCL) Capsules. This procurement aims to ensure an uninterrupted supply of Tamsulosin HCL for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and other federal healthcare facilities, with one contract awarded to a responsible offeror capable of meeting these needs over a base period of one year, plus four optional one-year extensions. The estimated annual requirements include approximately 1.4 million bottles of 90-count Tamsulosin HCL 0.4mg capsules, along with options for larger packaging sizes, highlighting the importance of consistent medicinal supply for veteran healthcare. Interested vendors should note that the solicitation will be released electronically on or about January 7, 2025, with responses due by January 21, 2025; inquiries can be directed to Contract Specialist Andrew Cazares at Andrew.Cazares@va.gov or (708) 786-4990.
    6505--Cyclobenzaprine Tablets (VA-25-00015093)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified contractors to supply Cyclobenzaprine HCL Tablets under solicitation number VA-25-00015093. The procurement involves providing pharmaceutical supplies over a base year and four option years, with specific requirements for submission formats, safety protocols, and compliance with drug supply chain security standards. Cyclobenzaprine is a critical medication used for muscle relaxation, making this procurement essential for ensuring consistent availability for veterans and healthcare facilities. Interested parties should contact Contract Specialist Kenneth Lay at Kenneth.Lay@va.gov for further details regarding the submission process and compliance requirements.
    6505--Carbidopa/Levodopa SA Tablet
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking pharmaceutical suppliers to establish a national contract for the provision of Carbidopa/Levodopa SA tablets through its Pharmaceutical Prime Vendor program. The Request for Proposal (RFP) outlines specific requirements for potential contractors, including pricing structures for the base year and four option years, compliance with the Drug Supply Chain Security Act, and the necessity for Good Manufacturing Practices (cGMP) status. This procurement is crucial for ensuring a reliable supply of essential medications for veteran and military healthcare systems across the nation. Interested parties should contact Contract Specialist Christopher Carthron at Christopher.Carthron@va.gov for further details regarding the proposal submission process and deadlines.
    6505--Diclofenac Sodium (NA) 1% Gel
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking to procure Diclofenac Sodium (NA) 1% Gel, a pharmaceutical product essential for pain management in patients. This presolicitation opportunity falls under the Pharmaceutical Preparation Manufacturing industry, specifically categorized under the NAICS code 325412 and PSC code 6505, indicating its relevance in the drugs and biologicals sector. The procurement aims to ensure the availability of this critical medication for veterans, highlighting its importance in providing effective treatment options. Interested vendors can reach out to Contract Specialist Ray Roldan at raymond.roldan@va.gov or call 708-786-4930 for further details regarding the solicitation process.